scispace - formally typeset
Journal ArticleDOI

Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man.

Manfred Gerlach, +1 more
- 01 Jan 1996 - 
- Vol. 103, Iss: 8, pp 987-1041
TLDR
The present contribution starts out by describing some of the clinical, pathological and neurochemical phenomena of Parkinson's disease, and hypotheses concerning the mechanisms of these neurotoxines have been related to the pathogenesis of nigral cell death in PD.
Abstract
Animal models are an important aid in experimental medical science because they enable one to study the pathogenetic mechanisms and the therapeutic principles of treating the functional disturbances (symptoms) of human diseases Once the causative mechanism is understood, animal models are also helpful in the development of therapeutic approaches exploiting this understanding On the basis of experimental and clinical findings Parkinson's disease (PD) became the first neurological disease to be treated palliatively by neurotransmitter replacement therapy The pathological hallmark of PD is a specific degeneration of nigral and other pigmented brainstem nuclei, with a characteristic inclusion, the Lewy body, in remaining nerve cells There is now a lot of evidence that degeneration of the dopaminergic nigral neurones and the resulting striatal dopamine-deficiency syndrome are responsible for its classic motor symptoms akinesia and bradykinesia PD is one of many human diseases which do not appear to have spontaneously arisen in animals The characteristic features of the disease can however be more or less faithfully imitated in animals through the administration of various neurotoxic agents and drugs disturbing the dopaminergic neurotransmission The cause of chronic nigral cell death in PD and the underlying mechanisms remain elusive The partial elucidation of the processes underlie the selective action of neurotoxic substances such as 6-hydroxydopamine (6-OHDA) or 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), has however revealed possible molecular mechanisms that give rise to neuronal death Accordingly, hypotheses concerning the mechanisms of these neurotoxines have been related to the pathogenesis of nigral cell death in PD The present contribution starts out by describing some of the clinical, pathological and neurochemical phenomena of PD The currently most important animal models (eg the reserpine model, neuroleptic-induced catalepsy, tremor models, experimentally-induced degeneration of nigro-striatal dopaminergic neurons with 6-OHDA, methamphetamine, MPTP, MPP+, tetrahydroisoquinolines, β-carbolines, and iron) critically reviewed next, and are compared with the characteristic features of the disease in man

read more

Citations
More filters
Journal ArticleDOI

Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease.

TL;DR: Recent data concerning the biochemical and molecular apoptotic mechanisms underlying the experimental models of PD are reported and correlates them to the phenomena occurring in human disease.
Journal ArticleDOI

Multi-Target-Directed Ligands To Combat Neurodegenerative Diseases

TL;DR: The aims of the present article are to discuss the role of ligand modification in the discovery of clinically efficacious drugs and the role that ligands endowed with outstanding in vitro selectivity have in this area.
Journal ArticleDOI

Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53 → Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice

TL;DR: It is demonstrated that the A53T mutant α-synuclein causes significantly greater in vivo neurotoxicity as compared with other α-Syn variants, and α- synuclein-dependent neurodegeneration is associated with abnormal accumulation of detergent-insoluble α- Syn.
Journal ArticleDOI

Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP.

TL;DR: The most important properties of 6-hydroxy-dopamine and MPTP, their modes of administration, and critically examines advantages and limitations of selected animal models are discussed.
Journal ArticleDOI

Proteasomal function is impaired in substantia nigra in Parkinson's disease.

TL;DR: Observations provide the first direct evidence that inhibition of the ubiquitin-proteasome pathway leading to altered protein handling and Lewy body formation may be responsible for degeneration of the nigrostriatal pathway in idiopathic PD.
References
More filters
Journal ArticleDOI

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

TL;DR: It is proposed that this chemical selectively damages cells in the substantia nigra in patients who developed marked parkinsonism after using an illicit drug intravenously.
Journal ArticleDOI

Reactive Oxygen Species and the Central Nervous System

TL;DR: The nature of antioxidants is discussed, it being suggested that antioxidant enzymes and chelators of transition metal ions may be more generally useful protective agents than chain‐breaking antioxidants.
Journal ArticleDOI

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.

TL;DR: A clinical, morphological and neurochemical correlative study in patients with Parkinson's syndrome and Huntington's chorea is reported in this paper, where positive correlations can be established, within a certain range, between the severity of individual Parkinsonian symptoms (especially akinesia and tremor) and the degree, and also the site, of the disturbance of dopamine metabolism within the nuclei of the basal ganglia; and the sensitivity of the patients to levodopa's acute anti-akinesia effect.
Journal ArticleDOI

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

TL;DR: The N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey provides a model that can be used to examine mechanisms and explore therapies of parkinsonism and the pathological and biochemical changes produced by NMPTP are similar to the well-established changes in patients with parkinsonistan.
Journal ArticleDOI

Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.

TL;DR: The nigrostriatal dopamine system of rats is unilaterally lesioned by intracerebral injection of 6-hydroxy-dopamine which produces an almost complete and selective lesion and the remaining contralateral dopamine system is activated by systemic treatment with amphetamine.
Related Papers (5)